Skip to content
Screener

Solventum SOLV EPS (Diluted)

EPS (Diluted) at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$1.64-18.0%
3M logo
3MMMM
$1.78+32.8%
Sanara MedTech Inc. logo
Sanara MedTech Inc.SMTI
$0.05+112%
UnitedHealth Group logo
UnitedHealth GroupUNH
$6.90+0.7%
DENTSPLY SIRONA logo
DENTSPLY SIRONAXRAY
$0.18+182%
Align Technology logo
Align TechnologyALGN
$1.51-12.2%

Other financials

Income statement

See full
Revenue$2.2B+2.2%
Gross profit$1.3B+9.4%
Operating income$181.0M-15.4%
Net income$92.0M+2.2%

Balance sheet

See full
Cash & equivalents$403.0M-18.1%
Total debt$5.8B-25.9%
Total equity$4.8B+31.7%
Total assets$14.2B-5.5%

Cash flow

See full
Operating cash flow$227.0M+34.3%
CapEx$83.0M-24.5%
Free cash flow-$273.0M-241%

Valuation

See full
Market cap$15.23B+20.6%
Enterprise value$20.62B+3.3%
P/E10.6×-22.6×
P/S1.8×+0.3×

Profitability

See full
Gross margin54.7%+0.2pp
Operating margin25%+15.7pp
Net margin17.3%+12.7pp
FCF margin4.6%-13.9pp

Returns & leverage

See full
Return on equity34%+22.3pp
Debt / equity1.2×-0.9×
Current ratio-0.2×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Solventum’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:27 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001964738-26-000047
(Millions, except per share data)Three months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Provision for (benefit from) income taxes151319(86)
Net income$92$90$105$227
Earnings per share:
Basic earnings per share$0.53$0.52$0.60$1.31
Diluted earnings per share0.530.510.601.30
Weighted-average number of shares outstanding:
Basic172.7174.1173.5173.9
Diluted173.3175.2174.4175.0

Item 1. Financial Statements

FAQ

What is Solventum's EPS (diluted)?
Solventum (SOLV) reported EPS (diluted) of $0.53 in Q2 2026.
How has Solventum's EPS (diluted) changed year-over-year?
Solventum's EPS (diluted) increased by 3.9% year-over-year, from $0.51 to $0.53.
What is the long-term trend for Solventum's EPS (diluted)?
Over 3 years (2022 to 2025), Solventum's EPS (diluted) has grown at a 4.4% compound annual growth rate (CAGR), from $7.78 to $8.86.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Solventum's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude